Neurogastrx is a specialty pharmaceutical company developing transformative therapies to advance the treatment of gastrointestinal (GI) disorders. They focus on developing treatments for GI disorders for which meaningful therapeutic innovation is required to satisfy unmet patient need and disease burden.

Biotechnology

Neurogastrx

Neurogastrx's headquarters in Woburn, MA, United States

Jim O’Mara

Pam Riarh

Deborah Corbelle

Paul Rogers

James Detore

Jay Pasricha

Klaus Veitinger

David Allison

Kevin Koch

Aaron Royston

Colin Howden

The Leadership Team at Neurogastrx is responsible for setting the strategic vision and direction of the company, ensuring alignment across all departments to advance the development of innovative therapies for gastrointestinal disorders. Comprising key executives such as the Chief Medical Officer and Chief Commercial Officer, the team focuses on driving research, overseeing financial health, and enhancing market positioning to meet unmet patient needs effectively. Their collaborative efforts are essential in navigating the complexities of pharmaceutical innovation and regulatory landscapes.

Leadership Team

The Scientific and Medical Team at Neurogastrx spearheads research and development efforts for innovative GI therapies. They are responsible for clinical trial design, regulatory compliance, and ensuring that emerging treatments meet rigorous medical standards, addressing unmet patient needs in the gastrointestinal field.

Neurogastrx

Org chart

Board & advisors

Teams

Leadership Team

Scientific and Medical Team

Offices

Neurogastrx

Org chart

Board & advisors

Teams

Leadership Team

Scientific and Medical Team

Offices

Related companies